Cite
HARVARD Citation
Cosenza, S. et al. (n.d.). 172 RIGOSERTIB, A NOVEL RAS INHIBITOR, OVERCOMES AZACITIDINE RESISTANCE IN ACUTE MYELOID LEUKEMIA CELL LINES. Leukemia research. 39 (1), pp. S87-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cosenza, S. et al. (n.d.). 172 RIGOSERTIB, A NOVEL RAS INHIBITOR, OVERCOMES AZACITIDINE RESISTANCE IN ACUTE MYELOID LEUKEMIA CELL LINES. Leukemia research. 39 (1), pp. S87-. [Online].